• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513750
Device Problems Failure to Advance (2524); Activation, Positioning or Separation Problem (2906)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/20/2023
Event Type  malfunction  
Manufacturer Narrative
The initial reporter facility name (b)(6) hospital.Imdrf device code a15 captures the reportable event of stent partially deployed.
 
Event Description
It was reported to boston scientific corporation on february 15, 2023, that an ultraflex esophageal ng distal release covered stent was to be implanted in the esophagus to treat an invasive 9 cm stenosis due to esophageal cancer during an endoscopic esophageal stent implantation procedure performed on (b)(6) 2023.The patient's anatomy was tortuous and was not dilated prior to stent placement.During the procedure, the physician was having difficulty reaching the posterior segment of the stenosis, so the lesion was dilated with an endoscope.The ultraflex esophageal stent was then attempted to be deployed, but it could not be deployed normally despite repeatedly rotating the device.The stent was removed from the patient partially deployed on the delivery system, and another ultraflex esophageal stent was implanted to complete the procedure.There were no reported patient complications as a result of this event.The patient's condition following the procedure was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on february 15, 2023, that an ultraflex esophageal ng distal release covered stent was to be implanted in the esophagus to treat an invasive 9 cm stenosis due to esophageal cancer during an endoscopic esophageal stent implantation procedure performed on (b)(6) 2023.The patient's anatomy was tortuous and was not dilated prior to stent placement.During the procedure, the physician was having difficulty reaching the posterior segment of the stenosis, so the lesion was dilated with an endoscope.The ultraflex esophageal stent was then attempted to be deployed, but it could not be deployed normally despite repeatedly rotating the device.The stent was removed from the patient partially deployed on the delivery system, and another ultraflex esophageal stent was implanted to complete the procedure.There were no reported patient complications as a result of this event.The patient's condition following the procedure was reported to be stable.
 
Manufacturer Narrative
Block e1: the initial reporter facility name is the sixth affiliated hospital of (b)(6) university.Block h6: imdrf device code a15 captures the reportable event of stent partially deployed.Block h10: the ultraflex esophageal ngf distal covered stent was returned, but the delivery system was not received for analysis.Visual inspection revealed no damage to the stent.Product analysis did not confirm the reported device malfunction of stent partially deployed because inspection of the returned stent revealed that the stent was completely deployed, and no damages were noted.Moreover, the reported malfunction of delivery system difficult to cross lesion cannot be confirmed as it occurred during the procedure and was not possible to replicate in the laboratory.Therefore, review and analysis of all available information indicated that the most probable cause is no problem detected.A product labeling review identified that the device was used per the instructions for use (ifu)/product label.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16489410
MDR Text Key310788090
Report Number3005099803-2023-01148
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729649113
UDI-Public08714729649113
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/25/2023
Device Model NumberM00513750
Device Catalogue Number1375
Device Lot Number0026687908
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/15/2023
Initial Date FDA Received03/06/2023
Supplement Dates Manufacturer Received04/12/2023
Supplement Dates FDA Received05/02/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/25/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age58 YR
Patient SexMale
Patient Weight75 KG
-
-